详情页

当前位置：首页 > 详情页

MDM4 polymorphisms associated with the risk but not the prognosis of esophageal cancer in Cixian high-incidence region from northern China.

14| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Hebei Provincial Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [2]Department of Surgery, Shijiazhuang Ping’an Hospital, Shijiazhuang, China

出处：

DOI：

ISSN：

关键词： esophageal squamous cell carcinoma mouse double minute 4 polymorphism risk survival

摘要：

The mouse double minute 4 (MDM4) may contribute to tumorgenesis by inhibiting p53 tumor suppressor activity. This study was designed to investigate whether MDM4 polymorphisms could affect susceptibility to esophageal squamous cell carcinoma (ESCC) and the survival of ESCC patients in a population from Cixian high-incidence region of northern China, which has not been explored.MDM4 rs1380576 and rs4245739 were genotyped by polymerase chain reaction-ligase detection reaction (PCR-LDR) in 568 ESCC patients and 578 controls.Compared to rs1380576 C/C genotype, C/G genotype was associated with decreased risk of ESCC (odds ratio [OR] = 0.761, 95% confidence interval [CI] = 0.595-0.973). Compared to rs4245739 A/A genotype, A/C or C/C genotype was related to increased susceptibility to ESCC (OR = 1.551, 95% CI = 1.001-2.402). Individuals with GC haplotype had significantly higher risk of ESCC than those with CA or GA haplotype (OR = 1.598, 95% CI = 1.048-2.438). Neither rs1380576 nor rs4245739 influenced the survival of ESCC patients.rs1380576 and rs4245739 may be used to predict susceptibility to ESCC for population in Cixian high-incidence region.© 2022 John Wiley & Sons Australia, Ltd.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院分区：

出版当年[2022]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

最新[2025]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

JCR分区：

出版当年[2022]版：

Q4 ONCOLOGY

最新[2024]版：

Q4 ONCOLOGY

影响因子： 1.6 最新[2024版] 1.6 最新五年平均 1.9 出版当年[2022版] 2.1 出版当年五年平均 1.926 出版前一年[2021版] 1.4 出版后一年[2023版]

第一作者：

第一作者机构： [1]Hebei Provincial Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [*1]HebeiProvincial Cancer Institute, The Fourth Hospital ofHebei Medical University, 12 Jiankang Road, Shijiazhuang, 050011, HebeiProvince, China.

通讯作者：

通讯机构： [1]Hebei Provincial Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [*1]HebeiProvincial Cancer Institute, The Fourth Hospital ofHebei Medical University, 12 Jiankang Road, Shijiazhuang, 050011, HebeiProvince, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]TIM-3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression. [2]Programmed death-1 ligand-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers [3]Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma [4]Development of a prognostic nomogram for esophageal squamous cell carcinoma patients received radiotherapy based on clinical risk factors [5]Risk factors for tumor recurrence in patients with pT3N0M0 thoracic esophageal squamous cell carcinoma after esophagectomy. [6]CDH1 gene rs1801552 C/T polymorphism increases susceptibility to esophageal squamous cell carcinoma but not to gastric cardiac adenocarcinoma. [7]TIM-3 Polymorphism Regulates Gene Expression and is Associated with the Susceptibility and Clinical Prognosis of Esophageal Squamous Cell Carcinoma. [8]A Genetic Polymorphism at miR-526b Binding- Site in the lincRNA- NR_ 024015 Exon Confers Risk of Esophageal Squamous Cell Carcinoma in a Population of North China [9]The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China [10]Consolidation Chemotherapy Provided Survival Benefit for Esophageal Squamous Cell Carcinoma Patients Who Underwent Concurrent Chemoradiotherapy Lower Than 60 Gy